Traditional Herbal Medicine, Sipjeondaebo-Tang, for Cancer-Related Fatigue: A Randomized, Placebo-Controlled, Preliminary Study
- PMID: 34672230
- PMCID: PMC8543707
- DOI: 10.1177/15347354211040830
Traditional Herbal Medicine, Sipjeondaebo-Tang, for Cancer-Related Fatigue: A Randomized, Placebo-Controlled, Preliminary Study
Abstract
Purpose: Sipjeondaebo-tang (SDT) is a widely used traditional herbal medicine for relieving fatigue. This randomized, placebo-controlled, preliminary study evaluated SDT for cancer-related fatigue, which is the most common symptom experienced by patients with cancer.
Patients and methods: Patients with a Brief Fatigue Inventory (BFI) score of at least 4 were randomly assigned in a double-blinded manner to receive SDT (3 g 3 times daily) or placebo orally for 3 weeks. The BFI was the primary outcome measure and secondary outcome measures included the Hospital Anxiety and Depression Scale (HADS), the European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire (EORTC QLQ-C30), immunoregulatory tests, and safety.
Results: A total of 50 participants were randomly assigned and 48 patients completed the trial. Based on intention-to-treat analysis, fatigue, which was the primary outcome, was improved in both arms compared with the baseline, and was significantly better in the SDT group than in the placebo group at week 3 (3.56 ± 1.18 vs 4.63 ± 1.83, P = .019). Secondary outcomes, including anxiety, depression, and immunoregulatory tests, did not improve significantly in either group. However, quality of life measured using the EORTC QLQ-C30 improved in both arms compared with the baseline, and the global health subscale was significantly better in the SDT group than in the placebo group (P = .02). No significant toxicities were observed.
Conclusion: SDT may improve cancer-related fatigue and quality of life in patients with cancer. A further randomized clinical trial with large sample size is warranted.
Keywords: Sipjeondaebo-tang; brief fatigue inventory; cancer-related fatigue; cancer-related symptoms; traditional herbal medicine.
Conflict of interest statement
Figures
Similar articles
-
Sipjeondaebo-tang in patients with breast cancer with fatigue: a protocol for a pilot, randomised, double-blind, placebo-controlled, cross-over trial.BMJ Open. 2018 Jul 6;8(7):e021242. doi: 10.1136/bmjopen-2017-021242. BMJ Open. 2018. PMID: 29982213 Free PMC article.
-
The efficacy and safety of Sipjeondaebo-tang in Korean patients with cold hypersensitivity in the hands and feet: a protocol for a pilot, randomized, double-blind, placebo-controlled, parallel-group clinical trial.Trials. 2019 Apr 15;20(1):217. doi: 10.1186/s13063-019-3286-7. Trials. 2019. PMID: 30987667 Free PMC article.
-
Efficacy and Safety of the Traditional Herbal Medicine, Gamiguibi-tang, in Patients With Cancer-Related Sleep Disturbance: A Prospective, Randomized, Wait-List-Controlled, Pilot Study.Integr Cancer Ther. 2018 Jun;17(2):524-530. doi: 10.1177/1534735417734914. Epub 2017 Oct 16. Integr Cancer Ther. 2018. PMID: 29034740 Free PMC article. Clinical Trial.
-
Effectiveness and safety of traditional Chinese medical therapy for cancer-related fatigue: a systematic review and Meta-analysis of randomized controlled trials.J Tradit Chin Med. 2020 Oct;40(5):738-748. doi: 10.19852/j.cnki.jtcm.2020.05.003. J Tradit Chin Med. 2020. PMID: 33000574
-
Chinese herbal medicine for post-viral fatigue: A systematic review of randomized controlled trials.PLoS One. 2024 Mar 21;19(3):e0300896. doi: 10.1371/journal.pone.0300896. eCollection 2024. PLoS One. 2024. PMID: 38512808 Free PMC article.
Cited by
-
Effects of botanical drugs in the treatment of cancer-related fatigue in patients with gastric cancer: A meta-analysis and prediction of potential pharmacological mechanisms.Front Pharmacol. 2022 Sep 7;13:979504. doi: 10.3389/fphar.2022.979504. eCollection 2022. Front Pharmacol. 2022. PMID: 36160404 Free PMC article.
-
Bibliometric and visualization analyses of cancer-related fatigue research published worldwide from 2001 to 2023.Front Oncol. 2024 Apr 30;14:1338325. doi: 10.3389/fonc.2024.1338325. eCollection 2024. Front Oncol. 2024. PMID: 38746672 Free PMC article.
-
Differences in Symptom Severity and Quality of Life among Patients with Cancer Using Conventional Therapies with/without Herbal Medicines in Uganda: A Cross-Sectional Study.Asian Pac J Cancer Prev. 2023 Sep 1;24(9):3195-3205. doi: 10.31557/APJCP.2023.24.9.3195. Asian Pac J Cancer Prev. 2023. PMID: 37774072 Free PMC article.
-
Analysis of Outcome Indicators of Cancer-Related Fatigue Treated with Chinese Herbal Compounding.Int J Gen Med. 2022 Dec 15;15:8603-8615. doi: 10.2147/IJGM.S383428. eCollection 2022. Int J Gen Med. 2022. PMID: 36545244 Free PMC article. Review.
-
Efficacy and safety of Piwei Peiyuan Prescription in the treatment of chronic atrophic gastritis: A multicenter, double-blind, double-simulated, randomized, controlled clinical trial.Medicine (Baltimore). 2024 May 10;103(19):e37981. doi: 10.1097/MD.0000000000037981. Medicine (Baltimore). 2024. PMID: 38728508 Free PMC article. Clinical Trial.
References
-
- Mock V, Atkinson A, Barsevick A, et al..; National Comprehensive Cancer Network. NCCN practice guidelines for cancer-related fatigue. Oncology. 2000;14:151-161. - PubMed
-
- Mock V. Fatigue management: evidence and guidelines for practice. Cancer. 2001;92:1699-1707. - PubMed
-
- Fulton C, Knowles G. Cancer fatigue. Eur J Cancer Care. 2000;9:167-171. - PubMed
-
- National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cancer-related fatigue. 2020. Accessed January 2, 2021. https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf
-
- Kirshbaum M. Cancer-related fatigue: a review of nursing interventions. Br J Commun Nurs. 2010;15:214-NaN6, 218. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical